Capecitabine and hand–foot syndrome
MW Saif - Expert opinion on drug safety, 2011 - Taylor & Francis
Hand–foot syndrome (HFS), or palmar-plantar erythrodysesthesia, is a common side effect
in patients taking long-term 5-fluorouracil treatment and is the most frequently reported side …
in patients taking long-term 5-fluorouracil treatment and is the most frequently reported side …
[HTML][HTML] Clinical management of cutaneous adverse events in patients on chemotherapy: a national consensus statement by the Spanish Academy of Dermatology …
O Sanmartín, C Beato, HJ Suh-Oh, I Aragón… - Actas Dermo …, 2019 - Elsevier
Although the arrival of new chemotherapy drugs and combinations has brought progress in
terms of cancer patient survival, they entail many adverse effects that can compromise …
terms of cancer patient survival, they entail many adverse effects that can compromise …
Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for …
K Murugan, V Ostwal, MD Carvalho, A D'souza… - Supportive Care in …, 2016 - Springer
Introduction Capecitabine is an oral prodrug of 5–fluorouracil and is commonly used oral
chemotherapeutic drugs for advanced gastric and colorectal cancer. However, hand-foot …
chemotherapeutic drugs for advanced gastric and colorectal cancer. However, hand-foot …
[HTML][HTML] Benign dermoscopic parallel ridge pattern in plantar hyperpigmentation due to capecitabine
L Tognetti, M Fimiani, P Rubegni - Dermatology practical & …, 2015 - ncbi.nlm.nih.gov
We report the case of a 37-year-old woman (phototype II) who presented at our outpatient
clinic with a two-month history of hyperpigmented plantar macules. Medical history revealed …
clinic with a two-month history of hyperpigmented plantar macules. Medical history revealed …
Anomalies pigmentaires induites par les traitements anticancéreux. Première partie: les chimiothérapies
V Sibaud, JC Fricain, R Baran, C Robert - Annales de Dermatologie et de …, 2013 - Elsevier
Résumé L'apparition d'une hyperpigmentation au cours des chimiothérapies est un des
effets indésirables dermatologiques les plus fréquemment constatés avec ces traitements …
effets indésirables dermatologiques les plus fréquemment constatés avec ces traitements …
Manejo clínico de los eventos adversos cutáneos en pacientes tratados con quimioterapia: consenso nacional de la Academia Española de Dermatología y …
O Sanmartín, C Beato, HJ Suh-Oh, I Aragón… - Actas Dermo …, 2019 - Elsevier
A pesar del avance que ha supuesto en la supervivencia de los pacientes oncológicos, la
aparición de nuevos agentes quimioterápicos y nuevas combinaciones, estos han traído …
aparición de nuevos agentes quimioterápicos y nuevas combinaciones, estos han traído …
[PDF][PDF] Capecitabine induced hand-foot syndrome: a systematic review of case reports
Objective: Capecitabine, a prodrug of 5-fluorouracil, is currently used in the treatment of
metastatic colorectal and breast cancers. The aim of this study was to review the …
metastatic colorectal and breast cancers. The aim of this study was to review the …
[HTML][HTML] Oral hyperpigmentation as an initial clinical aspect of hand foot syndrome
ÉG Santos-Leite, LV Sacramento, AM Santana… - Brazilian Dental …, 2022 - SciELO Brasil
Hand-foot syndrome (HFS) is a common adverse effect of anticancer therapy. It is known to
cause dermatological symptoms including acral erythema and dysesthesia of the palms and …
cause dermatological symptoms including acral erythema and dysesthesia of the palms and …
[PDF][PDF] Hyperpigmentation of the tongue, palms and soles: Rare side effect of capecitabine
J Zekri, EM Abdel-Ghany - J Cancer Res Ther, 2013 - nobleresearch.org
Cutaneous side effects of capecitabine include hand foot syndrome which manifests as
erythema, swelling and/or desquamation. We report a case on capecitabine treatment …
erythema, swelling and/or desquamation. We report a case on capecitabine treatment …